Janssen Search
Search results
John Gerecitano, M.D., Ph.D.
JOHN GERECITANO, M.D., PH.D. GLOBAL MEDICAL HEAD LYMPHOMA/LEUKEMIA DISEASE AREA LEADER ONCOLOGY RESEARCH & DEVELOPMENT JOHNSON & JOHNSON INNOVATIVE MEDICINE John Gerecitano, M.D., Ph.D. is the Global Medical Head of the Lymphoma/Leukemia Disease ...
Celebrating Our Progress toward an Effective HIV Vaccine
Celebrating Our Progress toward an Effective HIV Vaccine Today marks an exciting milestone: the full enrollment of volunteers in the first efficacy study for Janssen’s investigational preventive HIV vaccine. The Imbokodo study is designed to help ...
Richard Tillyer, Ph.D.
RICHARD TILLYER, Ph.D. Global Head Discovery and Manufacturing Sciences Richard Tillyer, Ph.D, is Global Head, Discovery and Manufacturing Sciences, Johnson & Johnson Innovative Medicine. In this role, he leads an integrated discovery and ...
Janssen Enters Worldwide Collaboration and License Agreement with Cellular Biomedicine Group to Develop Next Generation CAR-T Therapies
May 02, 2023 United States Investigational CD20-targeted CAR-Ts Enhance Janssen’s B-cell Malignancy Portfolio Agreement Deepens Janssen’s Leadership in Oncology and Hematology, and Accelerates Commitment to Delivering Transformational Cell Therapies ...
Richard (Dick) Insel, M.D.
RICHARD (DICK) INSEL, M.D. GLOBAL HEAD HEALTHY BABY INITIATIVE WORLD WITHOUT DISEASE ACCELERATOR As Global Head, Healthy Baby Initiative, World Without Disease Accelerator (WWDA), Dick is leading a strategy focused on changing the trajectory of health for ...
Clinical Trials
How J&J is Prioritizing DE&I in Clinical Trial Design Janssen Global Development Leadership Share Commitment to All Involved in Clinical Research Post-Marketing Requirements Clinical Trials Investigator Databank: Cross-Industry Collaboration ...
New Research Platforms
Three New Research Platforms Focused on Redefining Healthcare Article Type: World Without Disease Accelerator Disease Interception Accelerator In early 2015, Janssen Research & Development launched three new research platforms that focus on disease ...
Disease Interception Accelerator
DIA and Type One Diabetes Presbyopia and Cataracts Perinatal Depression Oral Cavity and Oropharyngeal /Cervical Cancer Gestational Diabetes Mellitus Chronic Obstructive Pulmonary Disease Wendy Johnson and Her Hope for Disease Interception- block Oral ...
Recognizing World Arthritis Day 2017
Recognizing World Arthritis Day 2017 For more than three decades, Janssen Immunology has been focused on innovating for patients, because we understand the impact rheumatic diseases have on individuals, and their families, friends and loved ones. The ...
Rheumatology – Treating Rheumatoid Arthritis
Rheumatology: Leveraging Expertise in Biomarkers and Co-Diagnostics to Personalize Medicine For more than a decade, Janssen has been providing patients and physicians with important therapies to treat rheumatoid arthritis (RA) and other rheumatic diseases ...